论文信息 - Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer - 字舞流文

Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancer

J. F. Burrows | D. Longley | S. Caddick | D. Mager | R. Straubinger | V. Chudasama | S. Van Schaeybroeck | C. Scott | M. Greene | E. Robinson | N. Straubinger | Ting Chen | J. R. Baker | Jun Wang | D. Chan | Charlene Minx